- Home
- THRD vs DXLG Comparison
THRD vs DXLG Comparison
Compare THRD & DXLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- DXLG
- Stock Information
- Founded
- THRD 2019
- DXLG 1976
- Country
- THRD United States
- DXLG United States
- Employees
- THRD N/A
- DXLG N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- DXLG Clothing/Shoe/Accessory Stores
- Sector
- THRD Health Care
- DXLG Consumer Discretionary
- Exchange
- THRD Nasdaq
- DXLG Nasdaq
- Market Cap
- THRD 157.7M
- DXLG 128.2M
- IPO Year
- THRD 2022
- DXLG 1987
- Fundamental
- Price
- THRD $3.55
- DXLG $1.49
- Analyst Decision
- THRD Hold
- DXLG Buy
- Analyst Count
- THRD 3
- DXLG 2
- Target Price
- THRD $5.00
- DXLG $2.75
- AVG Volume (30 Days)
- THRD 343.0K
- DXLG 317.9K
- Earning Date
- THRD 05-14-2025
- DXLG 03-20-2025
- Dividend Yield
- THRD N/A
- DXLG N/A
- EPS Growth
- THRD N/A
- DXLG N/A
- EPS
- THRD N/A
- DXLG 0.05
- Revenue
- THRD N/A
- DXLG $467,015,000.00
- Revenue This Year
- THRD N/A
- DXLG $5.35
- Revenue Next Year
- THRD N/A
- DXLG $6.97
- P/E Ratio
- THRD N/A
- DXLG $29.50
- Revenue Growth
- THRD N/A
- DXLG N/A
- 52 Week Low
- THRD $3.18
- DXLG $1.42
- 52 Week High
- THRD $16.94
- DXLG $3.93
- Technical
- Relative Strength Index (RSI)
- THRD 42.90
- DXLG 24.47
- Support Level
- THRD $3.34
- DXLG $1.42
- Resistance Level
- THRD $3.68
- DXLG $1.65
- Average True Range (ATR)
- THRD 0.14
- DXLG 0.10
- MACD
- THRD 0.07
- DXLG -0.01
- Stochastic Oscillator
- THRD 62.86
- DXLG 10.77
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets.